Published in Cardiol Res Pract on December 14, 2015
Correlation between impedance cardiography and 6 min walk distance in atrial fibrillation patients. BMC Cardiovasc Disord (2016) 0.75
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med (1999) 9.40
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Increased mortality among patients taking digoxin--analysis from the AFFIRM study. Eur Heart J (2012) 3.52
Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol (2014) 3.09
Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA (1994) 2.40
Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data. Heart (2007) 2.26
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation. Int J Cardiol (2014) 2.12
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J (2015) 1.71
Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol (2007) 1.66
Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study. Can J Cardiol (2014) 1.52
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol (2015) 1.51
Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circ Heart Fail (2009) 1.47
Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database Syst Rev (2004) 1.06
Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF). Heart (2009) 0.96
Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol (2008) 0.94
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol (2014) 0.94
Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol (2015) 0.87
Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure. Am J Cardiol (2014) 0.87
Digoxin in patients with permanent atrial fibrillation: data from the RACE II study. Heart Rhythm (2014) 0.86
Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study. Rev Esp Cardiol (Engl Ed) (2014) 0.84
Recognition of digitalis intoxication in the presence of atrial fibrillation. Ann Intern Med (1967) 0.81
Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem. Circ Arrhythm Electrophysiol (2022) 0.75